Related Experiment Videos
Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons
C S Casley1, J M Land, M A Sharpe
1Division of Neurochemistry, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom.
Neurobiology of Disease
|September 25, 2002
Summary
Beta-amyloid peptides impair mitochondrial function in brain cells, leading to reduced energy production and oxidative stress. This Alzheimer's disease mechanism affects both neurons and astrocytes, with neurons being more vulnerable.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease is characterized by beta-amyloid plaques and impaired brain energy metabolism.
- The causal relationship between beta-amyloid and energy metabolism deficits, and their cell-type specificity, remains unclear.
Purpose of the Study:
- To investigate the impact of beta-amyloid on cellular energy metabolism and mitochondrial function in neurons and astrocytes.
- To determine if beta-amyloid-induced energy metabolism impairment is specific to neuronal cells.
Main Methods:
- Primary neuronal and astrocyte cultures were incubated with beta-amyloid (Aβ25-35).
- Mitochondrial enzyme activity, mitochondrial morphology (swelling), mitochondrial number, ATP levels, and reduced glutathione levels were measured.
Main Results:
- Aβ25-35 treatment decreased mitochondrial enzyme activity, induced swelling, and reduced mitochondrial number in both cell types.
- ATP concentrations significantly decreased in neurons (58%) and astrocytes (71%).
- Reduced glutathione levels were lowered in both neurons and astrocytes, indicating oxidative stress.
Conclusions:
- Extracellular Aβ25-35 induces mitochondrial dysfunction in both astrocytes and neurons, with neurons being more severely affected.
- Astrocyte mitochondrial impairment involved specific inhibition of complex I, while neurons exhibited a generalized loss of mitochondria.